Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
8
pubmed:dateCreated
1996-9-6
pubmed:abstractText
Patients with stage D2 prostate carcinoma are often treated initially with hormones to decrease endogenous testosterone. Therapy with diethylstilbestrol (DES), leuprolide, or bilateral orchiectomy has been reported to be equivalent. DES is the cheapest preparation, but has the potential for serious cardiovascular or thromboembolic complications. Flutamide is a novel antiandrogen with fewer side effects.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
0732-183X
pubmed:author
pubmed:issnType
Print
pubmed:volume
14
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2250-7
pubmed:dateRevised
2007-11-14
pubmed:meshHeading
pubmed-meshheading:8708714-Administration, Oral, pubmed-meshheading:8708714-Aged, pubmed-meshheading:8708714-Aged, 80 and over, pubmed-meshheading:8708714-Androgen Antagonists, pubmed-meshheading:8708714-Antineoplastic Agents, Hormonal, pubmed-meshheading:8708714-Cardiovascular Diseases, pubmed-meshheading:8708714-Diethylstilbestrol, pubmed-meshheading:8708714-Double-Blind Method, pubmed-meshheading:8708714-Flutamide, pubmed-meshheading:8708714-Humans, pubmed-meshheading:8708714-Logistic Models, pubmed-meshheading:8708714-Male, pubmed-meshheading:8708714-Middle Aged, pubmed-meshheading:8708714-Neoplasm Metastasis, pubmed-meshheading:8708714-Neoplasm Staging, pubmed-meshheading:8708714-Proportional Hazards Models, pubmed-meshheading:8708714-Prostatic Neoplasms, pubmed-meshheading:8708714-Remission Induction, pubmed-meshheading:8708714-Survival Rate, pubmed-meshheading:8708714-Thromboembolism, pubmed-meshheading:8708714-United States
pubmed:year
1996
pubmed:articleTitle
Double-blind, randomized study of primary hormonal treatment of stage D2 prostate carcinoma: flutamide versus diethylstilbestrol.
pubmed:affiliation
University of Rochester Cancer Center, New York, USA.
pubmed:publicationType
Journal Article, Clinical Trial, Comparative Study, Research Support, U.S. Gov't, P.H.S., Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Multicenter Study